宜宾玻尿酸注射价格(宜宾做个双眼皮需要多少钱) (今日更新中)

The Twitter account that once belonged to former Republican presidential candidate Herman Cain tweeted Sunday evening that new CDC info indicated that COVID-19 "isn't as deadly" as once thought — despite the fact that Cain himself died of the virus just weeks ago.Cain died of COVID-19 on July 30 — four weeks after his office announced that he had been hospitalized in connection with the disease.On Aug. 11, Cain's daughter said in an update on his website that his family and campaign staff would continue to post content on the web and operate under the moniker "The Cain Gang.""He would have wanted us to do this. And that's exactly what we're going to do," Cain's daughter, Dr. Melanie Cain Gallo, wrote on HermanCain.com.In the weeks since the announcement, Cain's Twitter account has actively been sharing news links from largely conservative-leaning news outlets. On Sunday evening, the account tweeted a link to a story about a recent CDC announcement stating that COVID-19 was only listed as the sole cause of death for 6% of those killed by the virus."It looks like the virus is not as deadly as the mainstream media first made it out to be," the "Cain Gang" wrote on Twitter. 1196

The US-backed Syrian Democratic Forces have detained a US citizen who had been fighting with ISIS in Syria, a US military official told CNN Thursday.The official added that it appeared that the American citizen surrendered to Kurdish elements of the Syrian Democratic Forces.A spokesperson for the US-led coalition fighting ISIS would not confirm that a US citizen was in the custody of the SDF, referring questions to the US State Department."We have seen those same reports and the SDF as our partner has taken an oath to make sure that any fighters that they capture that they maintain them and bring them to the proper authorities. In this case the proper authorities would be the equivalent of the department of state in the country," Col. Ryan Dillon told reporters at the Pentagon via a video conference from Baghdad."If this was a US citizen it would be the Department of State to find out the updates on that particular person," Dillon added.A State Department official told CNN that the department was aware of the reports but said that they "have no information to share at this time."The Justice Department and the FBI also declined to comment.The Daily Beast was first to report that a US citizen had been detained by the SDF.This isn't the first US citizen fighting for ISIS to be detained by US allies in the region. In March 2016 a US citizen was captured in Iraq by US-backed Kurdish Peshmerga forces.The number of US citizens traveling to Iraq and Syria to join ISIS is thought to be much smaller than other countries and regions such as Western Europe and coalition officials have noted that far fewer foreign fighters have joined ISIS in recent months as the terror group suffers set-backs on the battle field.ISIS' recent defeats have also caused an increase in the number of fighters surrendering to the SDF with Dillon telling reporters that five ISIS fighters, including a local commander, had surrendered this week alone.The-CNN-Wire 1966

The South Georgia Islands might not be permanently populated by humans, but it is an important sanctuary for penguins, seals and other various creatures in the South Atlantic.But a giant iceberg, A68a, could threaten the wildlife on the islands, according to the Government of South Georgia & the South Sandwich Islands.With the assistance of the Royal Air Force, the government has been tracking the iceberg’s movement toward the islands. While the islands do not have a permanent population, they are visited by tourists and others.According to the BBC, A68a was 150 kilometers from South Georgia. The concern is the iceberg could disrupt breeding for penguins on the island.“We are now entering the key part of the year for breeding," Mark Belchier, director of fisheries and environment for the government of South Georgia & the South Sandwich Islands, told BBC News."The nests have been built for gentoo penguins, and eggs will be laid soon. And the first seal pups have been born in the last fortnight," he added.The islands used to be populated on a more permanent basis as a small settlement ran a whaling station.Before air travel, the islands were used by explorers to prepare for treks to Antarctica. Whalers on the island also played a key role rescuing Sir Earnest Shackleton’s crew after his expedition became stranded on Antarctica’s Elephant Island. 1381

The U.S. regulators who will decide the fate of COVID-19 vaccines are taking an unusual step: Asking outside scientists if their standards are high enough.The Food and Drug Administration may have to decide by year’s end whether to allow use of the first vaccines against the virus. Thursday, a federal advisory committee pulls back the curtain on that decision process, debating whether the guidelines FDA has set for vaccine developers are rigorous enough.“We will not cut corners, and we will only use science and data to make that determination,” FDA Commissioner Stephen Hahn pledged at a meeting of the Milken Institute Wednesday.Exactly how much data his agency needs to be sure a vaccine is safe and effective is a key question for the advisers. An even bigger one: If the FDA allows emergency use of a vaccine before final testing is finished, will that destroy chances of ever learning just how well that shot -- and maybe competitors still being studied -- really work?“We can’t lose sight of the fact that it is in our societal interest to see these trials to completion,” said Dr. Luciana Borio, a former FDA acting chief scientist who will be watching the advisers’ debate.Plus, multiple vaccines are being studied -- shots made with different technologies that each have pros and cons.“The first vaccine is not necessarily the best vaccine,” cautioned Dr. M. Miles Braun, a former FDA scientist now with Georgetown University School of Medicine. If the trials aren’t allowed to finish, it may be difficult or impossible to ever know for sure.It’s a critical moment in FDA’s 114-year history. The government has spent billions to race a vaccine through a research process that usually takes years, and FDA faces unprecedented pressure from the Trump administration, fueling public skepticism that politics could overrule science.Interest is so high, FDA is airing the meeting on YouTube. Here are some key issues the committee will discuss:HOW MUCH EVIDENCE IS NEEDED?FDA is requiring manufacturers to do studies of at least 30,000 people to prove if a vaccine protects and how safe it is. Those studies must include adequate numbers of people at highest risk from COVID-19 -- older adults, minorities and anyone with underlying health problems.FDA has made clear that any vaccine must be at least 50% effective. And while the studies are designed to run for two years, companies may get enough evidence the shots are protective -- in at least some people -- to stop the trials early and seek what’s called an “emergency use authorization” for wider vaccinations.Despite White House objections, the FDA told vaccine makers earlier this month not to seek that speedier review until they’ve tracked at least half their trial participants for two months. With other vaccines, that’s about the amount of time when major side effects crop up.That’s not long enough, said the head of the non-profit ECRI Institute, which reviews medical technology for hospitals and insurers. In comments submitted to the advisory committee, ECRI’s Dr. Marcus Schabacker said FDA should require six months of follow-up.“Doing any less would simply risk too much, and the consequences may be severe,” he wrote. “A weak vaccine that loses public trust could poison the well for epidemic control for many years.”WOULD EMERGENCY USE DERAIL FULL ANSWERS ABOUT VACCINES?Normally when a study ends because of evidence that a vaccine is working, the participants who got dummy shots are offered the real thing.But if FDA allows emergency use of a COVID-19 vaccine, that’s not the same as having full proof the shot works, Borio cautioned.And if the participants in the placebo group are immediately offered the real shot, researchers may not be able to get answers about all the high-risk groups in the study — or tell how long the vaccine’s protection lasts, a process expected to take many more months.But Pfizer Inc., which with Germany’s BioNTech is developing one of the leading candidates, told FDA that if it’s granted emergency use authorization, it “would have an ethical obligation” to alert study participants who got a placebo and allow them vaccine access. The company wants FDA to look into “other scientifically and statistically sound methods” to determine long-term safety and effectiveness.Pfizer’s stance is likely to face pushback. The Infectious Diseases Society of America states that FDA’s panelists “should insist” that vaccine developers “present a compelling case” for how they will complete their trials if FDA grants early authorization of their vaccine.Clearing a vaccine based on premature or faulty data “could cause more harm” by “further eroding public confidence in all vaccines,” the group said.It’s an unprecedented dilemma. The FDA has previously allowed emergency use of only one vaccine, a decades-old shot that in 2005 was authorized to prevent anthrax poisoning.This time around, multiple COVID-19 vaccines are in the pipeline. Pfizer competitor Johnson & Johnson cautioned that early FDA clearance of one vaccine could “jeopardize integrity” of other ongoing trials if patients decide to drop out to seek the first cleared shot instead.The company asked regulators to explain what options are available to ensure completion of all ongoing COVID-19 vaccine trials.WHAT ABOUT LONG-TERM SAFETY MONITORING?Even a study of 30,000 people cannot spot a side effect that only strikes 1 in 100,000. So the government is planning extra scrutiny of every COVID-19 vaccine to hit the market.At first there will be limited doses given to just certain high-risk people -- and those early recipients are to get text messages daily for the first week after vaccination, and then weekly out to six weeks, asking how they’re feeling.FDA also will be checking databases of electronic health records and insurance claims, looking for any red flags.“There’s a kind of tracking that has to take place here on a massive basis that hasn’t taken place before,” said Dr. Jesse Goodman of Georgetown University, a former director of the FDA’s vaccine and biologics center.___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. 6274

The wrongful death lawsuit filed by the family of Rebecca Zahau focused Thursday on the thoroughness of the investigation, with the lead Sheriff's detective on the case taking the stand. Zahau's death was ruled a suicide by four different investigative agencies but the Zahau family believes Rebecca was murdered by her boyfriend's brother, Adam Shacknai. The questioning by David Elsberg, attorney for Adam Shacknai, was aimed at showing investigators left no stone unturned. Elsberg's initial focus was on dispelling the scream that a neighbor reported may have come from the Coronado mansion around the time of Rebecca's death.  As Adam Shacknai's attorney pointed at areas of an overhead projection screen of the Coronado mansion, Detective Tsuida said the reported scream actually came from an area northwest of the property, toward the beach, and not from the balcony area where Rebecca Zahau was found dead. The attorney also showed a series of photos of footprints on the balcony, including bare prints that would support Rebecca standing on the balcony and near the balcony's edge. The questioning by Elsberg went on to the collection of potential DNA evidence and the intricate detail work involved.  Detective Tsuida testified that none of Adam Shacknai's DNA was found on the rope or knife, or several other items that might suggest he had anything to do with her death. 1480

来源：资阳报